SCHEMBL7330659

SCHEMBL7330659

CC(C(N)=O)N(C(=O)C(Cc1ccccc1)CS(=O)(=O)N1CCCN(C)CC1)c1nccs1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 3/20 0.46
CTSS P25774 1/20 0.37
CHRM1 P11229 4/20 0.36
F10 P00742 5/20 0.35
OPRL1 P41146 1/20 0.35
HSD17B10 Q99714 1/20 0.34
F2 P00734 3/20 0.34
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
PLG P00747 1/20 0.33
PLAT P00750 1/20 0.33
PRSS1 P07477 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GCK P35557 1/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7330956 0.97 REN (0.46) RENCTSSCHRM1F10OPRL1
SCHEMBL7338907 0.89 KMT2A (0.41) RENCTSSF10OPRL1F2
SCHEMBL7337422 0.89 REN (0.40) RENCTSSF10OPRL1F2
SCHEMBL7333699 0.86 REN (0.38) RENCTSSF10OPRL1F2
SCHEMBL7339618 0.85 REN (0.45) RENCTSSCHRM1OPRL1HSD17B10
SCHEMBL7333037 0.85 REN (0.38) RENCHRM1F10HSD17B10ALDH1A1
SCHEMBL7338484 0.85 REN (0.38) RENCTSSCHRM1F10OPRL1
SCHEMBL7339920 0.84 REN (0.36) RENCTSSF10OPRL1F2
SCHEMBL7330654 0.84 REN (0.38) RENCTSSCHRM1OPRL1HSD17B10
SCHEMBL7338555 0.83 REN (0.36) RENCTSSCHRM1HSD17B10APOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5332742-A Ocular hypotensive ABBOTT LABORATORIES (US) 1994-07-26 US disclosed
US-5310740-A Congestive heart failure, hypotensive agents, antiglaucoma agents; side effect reduction ABBOTT LABORATORIES (US) 1994-05-10 US disclosed
US-5284849-A Treating hypertension and congestive heart failure ABBOTT LABORATORIES (US) 1994-02-08 US disclosed
EP-0456185-A2 Renin inhibitors ABBOTT LABORATORIES (US) 1991-11-13 EP disclosed